Rayne Rouce
Clinical Director, Immunotherapy Fellowship Program · Baylor College of Medicine
Credentials: · ·
History
- Present
Immunotherapy Fellowship Program · Baylor College of Medicine
- Present
- 2010–2011
2007–2010
Research
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Blood · 2017 · 402 citations
Blood Advances · 2020 · 376 citations
Engineering Natural Killer Cells for Cancer Immunotherapy
Review · Molecular Therapy · 2017 · 359 citations
14 papers
11 papers
7 papers
7 papers
6 papers
6 papers · 3 as a resident
5 papers · 2 as a fellow
5 papers
Grants
- 2007–2030
Baylor College of Medicine Cancer Center - Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $600.6K · Baylor College of Medicine
- 2025–2030
Houston Area Incubator for Kidney, Urologic, and Hematologic Research Training (Hai-Kuh)
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
Project lead · $308.8K · Baylor College of Medicine
- 2023–2027
Collaborative Union for Cancer Research, and Educational Development (CURED)
National Cancer Institute · P20
Contact PI · $1.1M · Baylor College of Medicine
- 2023–2027
2/2 Collaborative Union for Cancer Research and Educational Development (CURED)
National Cancer Institute · P20
PI · $1M · Texas Southern University
Clinical trials
- 2026–2043
Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine
- 2022–2040
CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)
Principal investigator · Withdrawn · Phase 1
Baylor College of Medicine
- 2021–2041
Principal investigator · Active not recruiting · Phase 1
Baylor College of Medicine
- 2017–2040
Principal investigator · Recruiting · Phase 1
Baylor College of Medicine